Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302) [Phase 3]
Phase 3 trial (OVA-302) evaluating Gleolan (5-ALA) for fluorescence-guided visualization in newly diagnosed or recurrent ovarian cancer is c…
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: FaCT Trial (Facilitated Cascade Testing Trial) [NA]
Clinical trial update for the FaCT Trial (Facilitated Cascade Testing Trial) sponsored by Weill Medical College of Cornell University; curre…
-
CLINICAL_TRIALS research · 2025-09-30Clinical Trial Update: A Clinical Study of SHR-A1811 Combined With Chemotherapy for Platinum Sensitive Recurrent Ovarian Cancer [Phase 1, Phase 2]
A phase 1/2 clinical study evaluating SHR-A1811 in combination with chemotherapy for platinum-sensitive recurrent ovarian cancer is currentl…
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study [Phase 2]
This clinical trial update describes a Phase 2 long-term treatment extension study of niraparib for participants who completed a prior GSK/T…
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: Clinical Evaluation of the Tiaoshen Anti-Cancer Regimen in Treating Psycho-Neurological Symptom Cluster in Ovarian Cancer [NA]
A clinical trial evaluation of the Tiaoshen Anti-Cancer Regimen for treating psycho-neurological symptom clusters in ovarian cancer; current…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO) [Phase 3]
Phase 3 trial MATAO is evaluating maintenance therapy with an aromatase inhibitor in epithelial ovarian cancers; the study is currently recr…
-
CLINICAL_TRIALS trial_result · 2025-09-25Clinical Trial Update: A Controlled Clinical Trial Assessing the Efficacy of Vitamin B Prophylaxis in Attenuating Paclitaxel-induced Neuropathy and the Imperative Use of Gabapentin in Diabetic Ovarian Cancer Patients and the Potential Effect on Disease Response. [NA]
Completed clinical trial evaluating vitamin B prophylaxis to reduce paclitaxel-induced neuropathy and assessing gabapentin use in diabetic o…
-
CLINICAL_TRIALS trial_result · 2025-09-25Clinical Trial Update: A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors [Phase 1]
Phase 1 trial of NKT3447 in adults with advanced or metastatic solid tumors has been terminated. The study encompassed indications including…
-
CLINICAL_TRIALS research · 2025-09-25Clinical Trial Update: Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C) [Phase 1, Phase 2]
This clinical trial update reports Eli Lilly's KRAS G12C inhibitor LY3537982 is being studied in Phase 1/2 trials across multiple KRAS G12C-…
-
CLINICAL_TRIALS trial_result · 2025-09-23Clinical Trial Update: Olaparib Real-world Utilization and Clinical Outcomes in France, Italy, and the UK
Real-world study of olaparib use and clinical outcomes in ovarian cancer patients in France, Italy, and the United Kingdom.
-
CLINICAL_TRIALS withdrawal · 2025-09-23Clinical Trial Update: REFRaME-O1: A Study to Investigate the Efficacy and Safety of Luveltamab Tazevibulin Versus Investigator's Choice (IC) Chemotherapy in Women With Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) Expressing FOLR1 [Phase 2, Phase 3]
The REFRaME-O1 trial evaluating Luveltamab Tazevibulin versus investigator's choice chemotherapy for FOLR1-expressing ovarian cancer and rel…
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: A Study of STRO-002, an Anti-Folate Receptor Alpha Antibody Drug Conjugate, in Combination With Bevacizumab in Epithelial Ovarian Cancer [Phase 1]
Phase 1 study evaluating STRO-002 in combination with bevacizumab for epithelial ovarian cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: Durvalumab and Tremelimumab in Treating Participants With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
A Phase 2 trial evaluating the combination of durvalumab and tremelimumab in participants with recurrent or treatment-refractory ovarian, fa…
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: Phase 2 Study of Pembrolizumab, DPX-Survivac Vaccine and Cyclophosphamide in Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer [Phase 2]
This is a Phase 2 clinical trial evaluating pembrolizumab in combination with the DPX-Survivac vaccine and cyclophosphamide for advanced ova…
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: Nudge to Gynecologic Oncology [NA]
A clinical trial update indicating the gynecologic oncology study is currently active but not recruiting, with conditions including ovarian …
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 study of ERX-315 in patients with metastatic breast, ovarian, endometrial, liver, or pancreatic cancers is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: Pembrolizumab and Carboplatin for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating pembrolizumab in combination with carboplatin for recurrent ovarian cancer, fallopian tube cancer, or primary perit…
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: AOH1996 for the Treatment of Refractory Solid Tumors [Phase 1]
AOH1996 is being studied in a Phase 1 trial for patients with refractory solid tumors, including osteosarcoma and several other sarcomas and…
-
CLINICAL_TRIALS trial_result · 2025-09-18Clinical Trial Update: Gonadal Dysgenesis Tissue Cryopreservation for Fertility Preservation [NA]
A clinical trial sponsored by the University of Colorado, Denver is recruiting to study gonadal dysgenesis tissue cryopreservation for ferti…
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: HRD Tests for Ovarian cancER [Phase 2]
Phase 2 clinical trial update evaluating homologous recombination deficiency (HRD) testing in ovarian cancer; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: First Line Treatment With Olaparib in Combination With Bevacizumab in HRD Positive Patients [Phase 4]
Phase 4 update on first-line treatment with olaparib in combination with bevacizumab for HRD-positive ovarian cancer patients.
-
CLINICAL_TRIALS trial_result · 2025-09-16Clinical Trial Update: Assessing the Time Demands of Cancer
Clinical trial update for NCT05708703 by the Masonic Cancer Center evaluating the time demands of cancer care in metastatic breast cancer an…
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer
Massachusetts General Hospital is sponsoring a study to develop a uterine lavage test for detecting ovarian cancer, and the trial is current…
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: Using Liquid Biopsy in Newly Diagnosed Patients With High Grade Adenocarcinoma of Ovarian Origin, Fallopian Tubes or Primary Peritoneal [NA]
An update on a trial sponsored by Institut de Cancérologie de Lorraine evaluating liquid biopsy in newly diagnosed high-grade adenocarcinoma…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Deciphering Mechanisms Underlying Cancer Immunogenicity [NA]
A clinical trial exploring mechanisms underlying cancer immunogenicity, sponsored by Institut Claudius Regaud; the study is currently recrui…